Noronha, V., Patil, V., Menon, N., Shah, M., Ostwal, V., Ramaswamy, A., Bhargava, P., Shah, S., Nawale, K., Shetake, A., Mathrudev, V., Sahu, L., Mehta, S., Deshmukh, C., Gaikwad, S., Chavan, S., Narayan, R., Ingale, R., Dhumal, S., Kaushal, R. K., Pai, T., Purandare, N., Janu, A., Chakrabarty, N., Sahu, A., Haria, P., Vaidyanathan, A., Trikha, M., Gedela, S., Banavali, S., Badwe, R. A., Prabhash, K. (2026). Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII). Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01546